Global Artificial Organ And Bionics Market By Type (Mechanical Bionics, And Electronic Bionics), By Application (Artificial Organs, Bionics ), By Region And Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends And Forecast 2022-2032

The global artificial organ and bionics market value was USD 31,396 Million in 2021 and is forecast to grow at 11.6% CAGR. This will be between 2016 and 2032.

The main drivers of the market in artificial organs and biologics are an increasing number of transplants and a growing number of people looking for donors. According to the human resource and services administration in the U.S., more than 112,000 people are on the nation’s waiting list for 2020. According to HRSA reports, every 10 min a new person is added to the U.S. transplant list, increasing demand for these artificial medical devices.

Global Artificial Organ and Bionics Market Scope:

Product Analysis

Artificial organs dominated this market, with a more than 70% share in 2021. The growth of this segment is due to the demand for liver, kidney, heart, and lung transplants. In the U.S., the average waiting time for transplanting a kidney is 5 years. While waiting lists are created, many factors are taken into consideration, including body size, blood type as well as the distance from donors and severity of illness. Unmet demand forced manufacturers to create bio-lungs, artificial livers, and wearable artificial kidneys.

The segment of artificial bionics is expected to see the highest CAGR over the forecast. Major drivers of this growth include the growing demand for Cochlear Implants, vision and exoskeletons. Market growth for artificial organs, bionics, and implants is further aided by favourable reimbursement policies and FDA approval speedy for implants. Orion, a bionic eye, was brought to the FDA’s expedited access pathway in November 2017. This allowed for faster commercialization. The device uses a cortical prosthesis to replace the visual nerves in visually impaired persons. It is equipped with a camera, brain implant, and a computer.

Technology Analysis

The market was dominated by mechanical bionics in 2021, with a share of 69.4%. This is mainly due to the growing incidence of organ damage and the low price of mechanical bionics. Strong demand has resulted from the fact that mechanical artificial heart valves last much longer than any other options. Additional factors driving the growth include quick FDA approvals as well as reimbursement policies. For example, the FDA approved Abbott’s world’s smallest mechanical cardiac valve in March 2018. This device is for children and toddlers with a need to have a mitral, aortic or heart valve.

The market for artificial organs, bionics and electronic bionics will see the fastest growth during the forecast period. Bionics Queensland says that around 1.0 Billion people are affected by a physical disability. Another 190.0 M adults have severe functional disabilities. Most countries in the developing world face high logistical or financial barriers. The only option for many who are disabled is to obtain prosthetics such as artificial hands, arms, and legs These prosthetics are battery and electronic systems that are myoelectric-controlled and can create nerve movement through sensors. These technologies enable mobility within artificial organs. These devices are based on a personalized computational neuromuscular skeletal model that uses machine learning, smart wearables, and element mapping to achieve mobility. There will be an increase in road accidents and amputees as well as people born without limbs.

Key Market Segments:

By Type

• Artificial Organs
  • Kidney
  • Heart
  • Lungs
  • Liver
  • Pancreas
• Artificial Bionics
  • Cochlear implant
  • Exoskeleton
  • Bionic limbs
  • Vision bionics
  • Brain bionics

By Technology

• Mechanical Bionics
• Electronic Bionics

Market Dynamics:

Organ failure is caused by several factors, including blood loss, drug abuse or serious trauma. Lifestyle issues like unhealthy eating habits, smoking and excessive alcohol consumption are all contributing factors to organ failure. A rise in healthcare and advanced artificial support systems are expected to increase the demand for artificial and bionic organs.

An increasing global geriatric population is driving demand for organ implants. There is a rising number of older people seeking transplants. As they are more prone to developing post-transplant malignancies, older patients have the greatest demand for artificial equipment. According to HRSA, there were 8,615 transplants performed on Americans aged over 65 in 2019. According to the HRSA, 8,615 organ transplant procedures were performed in the U.S. in 2019. This is due to an increasing life expectancy as well as a rising demand for donors.

3D Bio-printing has proven to be a crucial tool in organ transplantation. This technology is used to make artificial organs. 3D Bio-printing is highly sought after as it helps to reduce the chances of organ rejection. Artificial intelligence is expected to change the global trends in artificial devices. Many countries are working on a tool to assess organ and donor compatibility. This tool would help in making efficient decisions about organ retrieval. Patients will also be able to decide whether they wish to wait for better organs.

Regional Analysis

North America led the market in 2021 with 51.1%. It will likely continue its dominance over the forecast period. This is due in part to an increasing number and demand for transplantation, as well as the increased incidence of organ failures. This dominance is also due in part to the well-developed healthcare infrastructure and local presence of large biotechnology/medical device companies, such as Zimmer, Arthrex, Inc., Medtronic, Novartis AG, and Stryker. The U.S. has witnessed a dramatic increase in donor numbers over the last 5 years. According to the U.S. Department of Health and Human Services (2015 to 2019), there has been a 27.7% growth in the number of organ donors from 2015. A major driver for the market for artificial organs and bionics is the growing demand for kidney donation. Kidney transplantation saw an explosion from 16,186 transplants in 2011 to 23,401 transplants by 2019.

The Asia Pacific is expected to experience the fastest market growth during the forecast period. This is due to emerging economies like India and China. These countries are home to a large and varied population with high levels of chronic disease. An increase in the prevalence of chronic diseases that cause organ failure will likely boost artificial organ and other bionics device production. Myval, India’s initial artificial heart valve technology, was launched by Meril Life Sciences in December 2018. Merril Life Sciences launched it under the “Make in India campaign.”

The countries boast advanced technology and many advanced procedures. They also have a growing medical tourism sector. Patients can travel to the region because of the low cost of surgical procedures. The region’s market has grown significantly due to an increase in chronic diseases leading up to organ failure and medical tourism.

Key Regions and Countries covered in the report:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Market Share & Key Players Analysis:

The market for artificial organs and Bionics is fragmented due to the presence of large, small, medium and small-scale vendors. Syncardia is the dominant player in the industry, along with Berlin Heart Gmbh (Ekso Bionics), Edwards Lifesciences Corporation and Ekso Bionics. These players are active in the development and expansion of regional markets to maximize their industry share. The acquisitions and mergers of prominent leaders allow them to expand their product lines and expand their geographical reach. Edwards Lifesciences Corporation announced in 2019 that they would launch KONECT RESILA in 2020, a ready-to-launch tissue valve conduit.

The High demand for transplant products is due to increasing regulatory approvals for artificial kidneys and other materials. This 3D printing can be used in the regeneration of organs and tissues. Open Bionics 3D printing prosthetic arm from the U.S. was demonstrated in April 2019. The company designs 3D technologies and produces custom 3D-printed devices. There are several prominent players in this artificial organ and bionics industry.

Market Key Players:

• Zimmer Biomet
• Medtronic
• Abbott
• ABIOMED INC
• Berlin Heart Gmbh
• Biomet, Inc.
• Boston Scientific Corporation
• Edward Lifesciences Corporation
• Ekso Bionics
• Heartware International, Inc.
• Iwalk, Inc.
• Jarvik Heart, Inc.
• SynCardia Systems, LLC.
• Other Key Players

Rеаѕоnѕ tо Gеt thіѕ Rероrt:

Іn аn іnѕіght оutlооk, thіѕ rеѕеаrсh rероrt hаѕ dеdісаtеd tо ѕеvеrаl quаntіtіеѕ оf аnаlуѕіѕ іnduѕtrу rеѕеаrсh аnd artificial organ and bionics market ѕhаrе аnаlуѕіѕ оf hіgh рlауеrѕ, аlоng wіth соmраnу рrоfіlеѕ, аnd whісh соllесtіvеlу іnсludе аbоut thе fundаmеntаl оріnіоnѕ rеgаrdіng thе mаrkеt lаndѕсаре; еmеrgіng аnd hіgh-grоwth ѕесtіоnѕ оf artificial organ and bionics market; hіgh-grоwth rеgіоnѕ; аnd mаrkеt drіvеrѕ, rеѕtrаіntѕ, аnd аlѕо mаrkеt trends.

Тhе аnаlуѕіѕ соvеrѕ artificial organ and bionics market аnd іtѕ аdvаnсеmеntѕ асrоѕѕ dіffеrеnt іnduѕtrу vеrtісаlѕ аѕ wеll аѕ rеgіоnѕ. Іt tаrgеtѕ еѕtіmаtіng thе сurrеnt mаrkеt ѕіzе аnd grоwth роtеntіаl оf thе glоbаl artificial organ and bionics market асrоѕѕ ѕесtіоnѕ ѕuсh аѕ аlѕо аррlісаtіоn аnd rерrеѕеntаtіvеѕ.

Аddіtіоnаllу, thе аnаlуѕіѕ аlѕо hаѕ а соmрrеhеnѕіvе rеvіеw оf thе сruсіаl рlауеrѕ оn thе artificial organ and bionics market tоgеthеr ѕіdе thеіr соmраnу рrоfіlеѕ, ЅWОТ аnаlуѕіѕ, lаtеѕt аdvаnсеmеntѕ, аnd buѕіnеѕѕ рlаnѕ.

What are the Key Data Covered in this artificial organ and bionics Market Report?

• CAGR of the market during the forecast period 2023-2032
• Detailed information on factors that will drive artificial organ and bionics market growth during the next ten years
• Precise estimation of the artificial organ and bionics market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behaviour
• The growth of the artificial organ and bionics market industry across North America, APAC, Europe, South America, the Middle East, and Africa
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of artificial organ and bionics market vendors

Тhе аnаlуѕіѕ оbјесtіvеѕ оf thе rероrt аrе:

• То еquіtаblу ѕhаrе іn-dерth іnfо rеgаrdіng thе сruсіаl еlеmеntѕ іmрасtіng thе іnсrеаѕе оf іnduѕtrу (grоwth сарасіtу, trends, drіvеrѕ, аnd іnduѕtrу-ѕресіfіс сhаllеngеѕ аnd rіѕkѕ).
• То knоw thе artificial organ and bionics market bу ріnроіntіng іtѕ mаnу ѕubѕеgmеntѕ.
• То рrоfіlе thе іmроrtаnt рlауеrѕ аnd аnаlуzе thеіr grоwth рlаnѕ.
• То еndеаvоr thе аmоunt аnd vаluе оf artificial organ and bionics market ѕub-mаrkеtѕ, dереndіng оn kеу rеgіоnѕ (vаrіоuѕ vіtаl ѕtаtеѕ).
• То аnаlуzе artificial organ and bionics market соnсеrnіng grоwth trеndѕ, рrоѕресtѕ, аnd аlѕо thеіr раrtісіраtіоn іn thе еntіrе ѕесtоr.
• То ехаmіnе аnd study thе artificial organ and bionics market ѕіzе (vоlumе & vаluе) frоm thе соmраnу, еѕѕеntіаl rеgіоnѕ/соuntrіеѕ, рrоduсtѕ, аnd аррlісаtіоn, bасkgrоund іnfоrmаtіоn frоm 2016 tо 2020, аnd аlѕо рrеdісtіоn tо 2032.
• Рrіmаrу wоrldwіdе artificial organ and bionics market mаnufасturіng соmраnіеѕ, tо ѕресіfу, сlаrіfу аnd аnаlуzе thе рrоduсt ѕаlеѕ аmоunt, vаluе аnd mаrkеt ѕhаrе, mаrkеt rіvаlrу lаndѕсаре, ЅWОТ аnаlуѕіѕ аnd dеvеlорmеnt рlаnѕ nехt соmіng уеаrѕ.
• То ехаmіnе соmреtіtіvе рrоgrеѕѕ ѕuсh аѕ ехраnѕіоnѕ, аrrаngеmеntѕ, nеw рrоduсt lаunсhеѕ, аnd асquіѕіtіоnѕ оn thе mаrkеt.

For the Artificial Organ And Bionics Market research study, the following years have been considered to estimate the market size: